Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2003 | 03-2003 | |
| Cash Flows From Operating Activities | ||
| Net Income | -6,246 | -2,781 |
| Depreciation Amortization | 175 | 87 |
| Accounts payable and accrued liabilities | -465 | -226 |
| Other Working Capital | 297 | 65 |
| Other Operating Activity | 465 | 226 |
| Operating Cash Flow | $-5,774 | $-2,629 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -39 | -3 |
| Investing Cash Flow | $-39 | $-3 |
| Cash Flows From Financing Activities | ||
| Financing Cash Flow | $N/A | $N/A |
| Beginning Cash Position | 8,925 | 8,925 |
| End Cash Position | 3,112 | 6,293 |
| Net Cash Flow | $-5,813 | $-2,632 |
| Free Cash Flow | ||
| Operating Cash Flow | -5,774 | -2,629 |
| Capital Expenditure | -39 | -3 |
| Free Cash Flow | -5,813 | -2,632 |